Publish or perish


In ophthalmology, particular emphasis is placed on clinical research and publications in order to gain entrance to higher specialist training. However, the length of time from submission of an article to a committee for review through to its publication, has often acted as a deterrent to many people who just want their voice to be heard As a result, concerns were raised that the length of time and administration costs of completing this process may result in a decrease in publications by junior doctors.1,2

Moreover, scientific and clinical productivity in the form of research projects and clinical case report publications to journals is commonly considered an accurate measure on which to base career advancement. Hence, there was a great concern than the future generation of ophthalmologists would not be able to progress past a certain level because of the difficulties they may find in having their research published.

In 1997, UK multicentre research ethics committees were introduced in a bid to overcome difficulties with applications to multiple local committees. This was followed by the introduction, in 2004, of the new Central Office for Research Ethics Committees (COREC).

Have article submission patterns changed?

Case reports dominate

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.